Zhiguo Hou

2PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 14, 2025
PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial.

Yakun Wang, Jialin Lu, Xiaoyi Chong

|Jul 02, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Jianjun Qin, Liyan Xue, Anlin Hao

Pageof 1

Frequent Collaborators

1 joint publications

Xiaofeng Guo

1 joint publications

Lijie Tan

1 joint publications

Bin Li

1 joint publications

Zhigang Li